Exploring new antifungal treatments for Mucormycosis

A novel link between calcineurin, amino acid permease, and protein kinase A in virulence in Mucor

NIH-funded research Texas Tech University Health Scis Center · NIH-11050571

This study is looking at how a protein called calcineurin helps certain fungi grow and cause a serious infection called mucormycosis, with the goal of finding new ways to treat this infection for patients who need better options.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Tech University Health Scis Center NIH-funded
Lab location1 site (Lubbock, United States)
Project IDNIH-11050571 on NIH RePORTER

What this research studies

This research investigates the role of calcineurin, a protein involved in fungal growth, in the virulence of Mucorales fungi, which cause the life-threatening infection known as mucormycosis. The study aims to identify specific fungal pathways that can be targeted to develop new antifungal drugs, especially given the high levels of resistance seen in current treatments. By understanding how mutations in amino acid permease genes contribute to this resistance, the research seeks to create effective therapies for patients suffering from this severe infection.

Who could benefit from this research

Good fit: Ideal candidates for this research are immunocompromised individuals at risk of developing mucormycosis or those currently suffering from this infection.

Not a fit: Patients with mucormycosis caused by non-Mucorales fungi or those who are not immunocompromised may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antifungal medications that are effective against resistant strains of Mucorales, significantly improving patient outcomes.

How similar studies have performed: While the approach of targeting calcineurin in fungi is known, the specific focus on Mucorales and the development of novel antifungal strategies is relatively novel and has not been extensively tested.

Where this research is happening

Lubbock, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.